About Fc receptor-like protein 6
Fc receptor-like protein 6 (FCRL6) is a protein
from Homo sapiens identified by UniProt accession
Q6DN72, 434 residues long.
MolForge cross-references it against 0 known binders and
47 disease associations.
Target properties
| Protein name | Fc receptor-like protein 6 |
| UniProt accession | Q6DN72 |
| Gene | FCRL6 |
| Organism | Homo sapiens |
| Length | 434 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (47)
Diseases linked to this target (Open Targets).
- C-reactive protein measurement · score 0.05
- Rheumatoid arthritis · score 0.04
- neurofibrillary tangles measurement · score 0.03
- neoplasm · score 0.02
- protein measurement · score 0.02
- type 1 diabetes mellitus · score 0.01
- type 2 diabetes mellitus · score 0.01
- chronic periodontitis · score 0.01
- HIV-1 infection · score 0.01
- chronic lymphocytic leukemia · score 0.01
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q6DN72-F1 | alphafold | PREDICTED | 76.22 | — |
Amino-acid sequence (434 residues)
MLLWTAVLLF VPCVGKTVWL YLQAWPNPVF EGDALTLRCQ GWKNTPLSQV KFYRDGKFLH FSKENQTLSM GAATVQSRGQ YSCSGQVMYI PQTFTQTSET AMVQVQELFP PPVLSAIPSP EPREGSLVTL RCQTKLHPLR SALRLLFSFH KDGHTLQDRG PHPELCIPGA KEGDSGLYWC EVAPEGGQVQ KQSPQLEVRV QAPVSRPVLT LHHGPADPAV GDMVQLLCEA QRGSPPILYS FYLDEKIVGN HSAPCGGTTS LLFPVKSEQD AGNYSCEAEN SVSRERSEPK KLSLKGSQVL FTPASNWLVP WLPASLLGLM VIAAALLVYV RSWRKAGPLP SQIPPTAPGG EQCPLYANVH HQKGKDEGVV YSVVHRTSKR SEARSAEFTV GRKDSSIICA EVRCLQPSEV SSTEVNMRSR TLQEPLSDCE EVLC
Explore Fc receptor-like protein 6 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets